Evidence map›Paper›PMID 22399228›Full record

ArticleJournal of molecular neuroscience : MN2012

β2-adrenergic receptor and astrocyte glucose metabolism.

Jun-hong Dong, Xin Chen, Min Cui, Xiao Yu, Qi Pang, Jin-peng Sun

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 73 citations in OpenAlex.

  1. Cocaine facilitates CaMolecular psychiatry · 2026
    Article
  2. Sex-dimorphic betaScientific reports · 2025
    Article
  3. Implication of Central βArchiv der Pharmazie · 2025
    Review
  4. Article
  5. Neural Processing without OPhysiology (Bethesda, Md.) · 2024
    Review
  6. Neural circuits regulating visceral pain.Communications biology · 2024
    Review
  7. Article
  8. Review
  9. Multisensory Stimulation Reverses Memory Impairment in AdrβInternational journal of molecular sciences · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. βDrug testing and analysis · 2021
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jun-hong DongKey Laboratory for Experimental Teratology of the Ministry of Education, Department of Biochemistry and Molecular Biology, Shandong University School of Medicine, Jinan, Shandong 250012, People's Republic of China.
Xin Chen
Min Cui
Xiao Yu
Qi Pang
Jin-peng Sun
Shandong University · CNShandong Management University · CNShandong Provincial Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Astrocyte glucose metabolism functions to maintain brain activity in both normal and stress conditions. Dysregulation of astrocyte glucose metabolism relates to development of neuronal disease, such as multiple sclerosis and Alzheimer's disease. In response to acute stress, beta2-adrenergic receptor is activated and initiates multiple signaling events mediated by Gs, Gi, arrestin, or other effectors depending on specific cellular contexts. In astrocytes, beta2-adrenergic receptor promotes glucose uptake through GLUT1 and accelerates glycogen degradation via coupling to Gs and second messenger cAMP-dependent pathway. Beta2-adrenergic receptor may regulate other steps in astrocyte glucose metabolism, such as lactate production or transduction. Inappropriate regulation of beta2-adrenergic receptor activity can disrupt normal glucose metabolism, and leads to accelerate neuronal disease development. It was demonstrated that the absence of beta2-adrenergic receptor in astrocytes occurred in multiple sclerosis patients, and the increased beta2-adrenergic receptor activity relates to Alzheimer's disease. A clear view of beta2-adrenergic receptor-mediated signaling pathways in regulating astrocyte glucose metabolism could help us to develop neuronal diseases treatment by targeting to the beta2-adrenergic receptor.

Indexed as

Alzheimer DiseaseAnimalsAstrocytesCell CommunicationDisease Models, AnimalDown-RegulationGlucoseHumansMultiple SclerosisNeuronsReceptors, Adrenergic, beta-2Up-RegulationGlucoseReceptors, Adrenergic, beta-2

Identifiers

PMID22399228
OpenAlexW2044497058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.